D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea flag South Korea · Delayed Price · Currency is KRW
144,400
-9,700 (-6.29%)
Jul 21, 2025, 3:30 PM KST

D&D Pharmatech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
1,667,470513,608----
Upgrade
Enterprise Value
1,649,114494,061----
Upgrade
Last Close Price
154100.0048600.00----
Upgrade
PS Ratio
155.1444.91----
Upgrade
PB Ratio
26.397.38----
Upgrade
P/TBV Ratio
55.0014.45----
Upgrade
EV/Sales Ratio
153.4343.20----
Upgrade
Debt / Equity Ratio
0.140.140.151.470.320.03
Upgrade
Asset Turnover
-0.130.220.000.01-
Upgrade
Quick Ratio
3.163.202.280.471.146.63
Upgrade
Current Ratio
3.543.582.610.611.227.28
Upgrade
Return on Equity (ROE)
-57.28%-47.25%9.29%-174.72%-43.71%-38.23%
Upgrade
Return on Assets (ROA)
--17.70%-9.75%-24.89%-19.70%-16.52%
Upgrade
Return on Capital (ROIC)
-26.90%-21.91%-15.45%-37.70%-25.64%-25.07%
Upgrade
Earnings Yield
-1.98%-5.57%----
Upgrade
FCF Yield
-1.54%-4.32%----
Upgrade
Buyback Yield / Dilution
-14.93%-8.08%-16.38%2.05%-12.66%-118.38%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.